Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveOmeros to Terminate Yartemlea Compassionate-Use Program in Europe

Live News EQUITY FLASH L impact Oct 16, 2026, 10:34 AM UTC

Omeros to Terminate Yartemlea Compassionate-Use Program in Europe

Omeros will terminate the program due to U.S. demand.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

OMER

Related stories

Merck Says Intismeran Plus Keytruda Reduced Recurrence or Death Risk 42% M impact | EQUITY | Oct 22, 2026, 06:42 PM UTC Wall Street Falls as Nasdaq Drops More Than 2% on AI Cost Worries U.S. stocks fell Thursday, with the Nasdaq recording its steepest daily decline since early June. High-profile earnings reports renewed concerns about AI spending. M impact | EQUITY | Oct 22, 2026, 06:35 PM UTC Tractian Raises $130 Million in Series D at $1.4 Billion Valuation The physical AI startup’s funding round was led by Sapphire Ventures and co-led by M&G Investments’ Catalyst fund. M impact | EQUITY | Oct 22, 2026, 06:35 PM UTC US session market picture: S&P 500 -1.39%, Nasdaq 100 -2.85%; EUR/USD -0.08%, WTI +2.55%, WBD leads volume US session market picture. US index futures: S and P futures is down 1.39 percent, Nasdaq futures is down 2.85 percent, Dow futures is down 0.12 percent and Russell futures is down M impact | EQUITY | Oct 22, 2026, 06:30 PM UTC European Equities Fall on AI Spending Concerns, Conflicts and Higher Oil European stocks closed notably lower Thursday as concerns about AI infrastructure spending, Middle East and Russia-Ukraine conflicts, elevated oil prices and French debt weighed on M impact | EQUITY | Oct 22, 2026, 06:28 PM UTC Merck-Moderna Vaccine Cuts Melanoma Death or Recurrence Risk 42% Trial data show the mRNA vaccine, combined with a widely used immunotherapy, cut melanoma disease-spread risk by 38%. M impact | EQUITY | Oct 22, 2026, 06:25 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.